BPG is committed to discovery and dissemination of knowledge
Clinical Trials Study
©The Author(s) 2025.
World J Orthop. Dec 18, 2025; 16(12): 109963
Published online Dec 18, 2025. doi: 10.5312/wjo.v16.i12.109963
Table 1 Baseline demographic characteristics of study


Min-max
Median
mean ± SD/n (%)
Age55.0-83.065.065.3 ± 7.21
SexFemale25 (62.5)
Male15 (37.5)
OccupationUnemployed33 (82.5)
Active worker7 (17.5)
Educational statusUneducated1 (2.5)
Primary school14 (35)
Middle school10 (25)
High school12 (30)
University3 (7.5)
Sensory loss(-)24 (60)
(+)16 (40)
Incontinence(-)27 (67.5)
(+)13 (32.5)
Spinous process sensitivity(-)30 (75)
(+)10 (25)
Paravertebral muscle spasm(-)10 (25)
(+)30 (75)
Duration of pain30.0-450.0150.0216.1 ± 139.0
Hand-ground distance0.0-70.015.021.6 ± 20.9
Walking distance (m)10.0-600.0100.0143.8 ± 164.5
Visual pain score during movement5.0-10.08.08.1 ± 1.4
Visual pain score during resting0.0-8.03.53.4 ± 2.1
Visual pain score during night0.0-9.04.03.8 ± 2.8
ILBDI score11.0-81.040.040.1 ± 15.7
NEADL score12.0-56.031.533.4 ± 13.9
Symptom severity scale of SSS12.0-32.020.021.0 ± 5.4
Physical function scale of SSS5.0-90.010.014.5 ± 17.8


Write to the Help Desk